Skip to main content
. 2013 Sep 12;2(9):e26011. doi: 10.4161/onci.26011

Table 2. Variations in phenotypic and functional NK-cell parameters as detected in the circulation of multiple myeloma patients.

Ref. NK cell number Activation status Activating receptors Cytotoxicity Notes
44
Increased
 
 
Unchanged
Increased NK also in MGUS
45
Unchanged
Unchanged
 
 
 
46
Increased
 
 
Decreased
Increased NK also in MGUS
47
Increased in BM
 
 
 
Increased NK also in MGUS
48
 
 
Decreased CD16
Decreased CD244
Unchanged KLRK1
Unchanged NCR
 
Trend toward reduced KLRK1 levels in MM
49
 
 
Decreased KLRK1
 
Bortezomib increased MICA levels on MM cells
50
 
 
 
Decreased
Stage-dependent decrease
51
 
 
Decreased KLRK1
 
Not linked with soluble MICA levels
52 Increased also in BM        

Abbreviations: BM, bone marrow; KLRK1, killer cell lectin-like receptor subfamily K, member 1; MICA, HC class I polypeptide-related sequence A; MGUS, monoclonal gammopathy of undetermined significance; MM; multiple myeloma; NCR, natural cytotoxicity triggering receptor; NK, natural killer.